CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Open-label Therapeutic Trial Evaluating the Efficacy and Safety of Neridronate (Nerixia®) in the Treatment of Osteoporosis in Patients With Thalassemia Major and Severe Thalassemia Intermedia.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01140321
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:25.213461+00:00
Published At: 2020-02-05T00:00:00+00:00
Record Updated At: 2020-02-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Osteoporosis", "Thalassemia Major", "Thalassemia Intermedia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-05"
protocolSection.identificationModule.nctId: "NCT01140321"
protocolSection.identificationModule.officialTitle: "A Randomized, Open-label Therapeutic Trial Evaluating the Efficacy and Safety of Neridronate (Nerixia\u00ae) in the Treatment of Osteoporosis in Patients With Thalassemia Major and Severe Thalassemia Intermedia."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.